U.S. flag An official website of the United States government

On Oct. 1, 2024, the FDA began implementing a reorganization impacting many parts of the agency. We are in the process of updating FDA.gov content to reflect these changes.

U.S. Food and Drug Administration
  1. Home
  2. Inspections, Compliance, Enforcement, and Criminal Investigations
  3. Compliance Actions and Activities
  4. Warning Letters
  5. City Vapes Premium eJuice Inc. - 604021 - 10/22/2020
  1. Warning Letters

CLOSEOUT LETTER

City Vapes Premium eJuice Inc. MARCS-CMS 604021 —

Delivery Method:
VIA Electronic Mail
Reference #:
RW1901231
Recipient:
City Vapes Premium eJuice Inc.

United States

sales@cityvapes.com
doitbyecig@shaw.ca
Issuing Office:
Center for Tobacco Products

United States

The United States Food and Drug Administration’s (FDA) Center for Tobacco Products has completed an evaluation of your corrective actions in response to our Warning Letter dated February 28, 2020. Based on our evaluation, it appears that you have taken steps to address the violation contained in the Warning Letter for the website https://cityvapes.com.

This letter does not relieve you or your firm from the responsibility of taking all necessary steps to ensure compliance with the Federal Food, Drug, and Cosmetic Act and its implementing regulations or with other relevant legal authority. This letter also will not preclude any regulatory action should violations be observed in the future.

Sincerely,
/S/
David Rice
Branch Chief
Division of Promotion, Advertising, and Labeling
Office of Compliance and Enforcement
Center for Tobacco Products

Back to Top